Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings

Overview of attention for article published in PLOS ONE, August 2011

Altmetric Badge

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 70 Dimensions

Readers on

mendeley: 34 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

USE OF ICARITIN IN PREPARING MEDICAMENT FOR PREVENTING OR TREATING HEMATOCYTOPENIA

Application EP-3061452-A4

European Patent Office

USE OF ICARITIN IN PREPARING MEDICAMENT FOR PREVENTING OR TREATING HEMATOCYTOPENIA

Application EP-3061452-A1

European Patent Office

Use of icaritin for the preparation of composition for treating cancer

Grant US-9301942-B2

United States of America

Use of icaritin for the preparation of a composition for treating cancer

Application EP-2808016-A1

European Patent Office